Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
Jolieke G. van Oosterwijk(US Biologic (United States)), Sharyn D. Baker(The Ohio State University)
Cited by 39
Related Papers
Duplications of noncoding elements 5′ of SOX9 are associated with brachydactyly-anonychia
|Nature Genetics|2009|118
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)
|Pediatric Blood & Cancer|2017|73
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD–Positive AML
|Molecular Cancer Therapeutics|2021|45
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
|BMC Cancer|2012|43
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
|Nature Communications|2019|41